Lindbrook Capital’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $34.1K | Buy |
864
+37
| +4% | +$1.46K | ﹤0.01% | 1140 |
|
|
2024
Q4 | $24.9K | Buy |
827
+1
| +0.1% | +$30 | ﹤0.01% | 1152 |
|
|
2024
Q3 | $19.3K | Buy |
826
+72
| +10% | +$1.68K | ﹤0.01% | 1320 |
|
|
2024
Q2 | $13.4K | Buy |
754
+42
| +6% | +$747 | ﹤0.01% | 1474 |
|
|
2024
Q1 | $10.8K | Sell |
712
-70
| -9% | -$1.07K | ﹤0.01% | 1527 |
|
|
2023
Q4 | $13.4K | Buy |
782
+393
| +101% | +$6.71K | ﹤0.01% | 1388 |
|
|
2023
Q3 | $3.25K | Buy |
389
+44
| +13% | +$368 | ﹤0.01% | 1951 |
|
|
2023
Q2 | $8.57K | Buy |
345
+15
| +5% | +$373 | ﹤0.01% | 1559 |
|
|
2023
Q1 | $4.96K | Buy |
330
+27
| +9% | +$406 | ﹤0.01% | 1851 |
|
|
2022
Q4 | $3.58K | Buy |
303
+203
| +203% | +$2.4K | ﹤0.01% | 1975 |
|
|
2022
Q3 | $1K | Sell |
100
-240
| -71% | -$2.4K | ﹤0.01% | 2501 |
|
|
2022
Q2 | $1K | Sell |
340
-57
| -14% | -$168 | ﹤0.01% | 2377 |
|
|
2022
Q1 | $4K | Sell |
397
-721
| -64% | -$7.26K | ﹤0.01% | 1749 |
|
|
2021
Q4 | $21K | Sell |
1,118
-1,382
| -55% | -$26K | ﹤0.01% | 1003 |
|
|
2021
Q3 | $83K | Sell |
2,500
-500
| -17% | -$16.6K | 0.02% | 307 |
|
|
2021
Q2 | $116K | Buy |
3,000
+400
| +15% | +$15.5K | 0.03% | 264 |
|
|
2021
Q1 | $125K | Buy |
2,600
+1,100
| +73% | +$52.9K | 0.03% | 233 |
|
|
2020
Q4 | $78K | Buy |
1,500
+500
| +50% | +$26K | 0.02% | 288 |
|
|
2020
Q3 | $27K | Hold |
1,000
| – | – | 0.01% | 529 |
|
|
2020
Q2 | $19K | Buy |
+1,000
| New | +$19K | 0.01% | 627 |
|
|
2019
Q2 | – | Sell |
-1,000
| Closed | -$8K | – | 1506 |
|
|
2019
Q1 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 963 |
|
|
2018
Q4 | $4K | Buy |
+1,000
| New | +$4K | ﹤0.01% | 1076 |
|